PHENOTYPIC FEATURES OF ENDOMETRIAL CANCER AND MSI IN COLON AND BLOOD SERUM
DOI:
https://doi.org/10.14739/2310-1237.2014.1.25927Keywords:
endometrial cancer, microsatellite instability, colon cancer, blood serumAbstract
Since the end of the last century an upward trend regarding hormone-dependent tumours of the reproductive system, including endometrial cancer (EC) has been observed, with one of the trend reasons being increased number of mutations, in particular, microsatellite instability (MSI) – the consequence of unpaired nucleotides repair system gene inactivation (MSH2, MSH3, MSH6, MLH1,PMS2, EXO1).
This molecular genetic phenomenon may also be characteristic of certain colon cancer forms, while being detectable not only in the tumour but also in blood, which may be of clinical interest as regards either determining risk groups in terms of other localization malignant tumours development, especially colon cancer, or early diagnostics of the said diseases. However, relationship between clinical, phenotypic and molecular risk factors for EC and colon cancer needs further studying.
The aim of research – to estimate MSI frequency in blood serum and colonic mucosal lining in patients with EC.
Materials and methods. 342 patients with I – IV stage EC aged between 30 and 80 underwent MSI determining in tumour tissue, blood serum and colonic mucosa by means of polymerase chain reaction method using primers for microsatellite sequence (ВАТ-25, ВАТ-26). Colonic mucosal lining samples were obtained by colonoscopy prior to surgical intervention.
Genomic DNA purification from blood serum was performed using DNA purification kit produced by Silex M Scientific and Production Company (Russia), in accordance with manufacturer's instructions. PCR was performed by the standard procedure using Tertsik-2 programmable thermal cycler produced by DNA – Technology LTD, Russia. The studies were carried out at Virola laboratory at Kharkiv Medical Academy of Postgraduate Education. Ethics and Bioethics Committee permit (minutes No.4 of 18.04.2013, Kharkiv Medical Academy of Postgraduate Education). The obtained digital study results were processed by means of conventional variation statistics methods using the χ2 criterion.
Results. Estimation of MSI occurrence frequency in the colon tissue showed that MSI- colonic tissue is significantly more frequent (93.9 %) compared to MSI+ (6.1 %), p<0.01.
Analysis of MSI occurrence frequency in case of EC showed that MSI is significantly more frequently observed in blood serum (10.8 % of cases) than in the colonic tissue (mucosal lining) (6.1 %). A similar pattern was observed also in cases with MSI+ tumour phenotype (MSI frequency in colonic mucosal lining made 12.2 %, whereas in blood serum – 29.6 %, p <0.01).
Analysis of indices in cases with MSI- tumour phenotype demonstrated inverse relation, i.e. genome microsatellite instability was more frequently observed in the colonic mucosal lining than in blood serum (p<0.05).
We have carried out analysis of the MSI occurrence frequency in colonic tissue depending on the EC phenotypic traits and risk factors. The obtained data on the MSI disorder occurrence frequency in colonic tissue in case of EC depending on the endometrial carcinoma risk factors demonstrated correlation with the majority of criteria, thus verifying the literature data on the presence of common pathogenetic mechanisms in case of EC and colon cancer.
Conclusions. 1. MSI disorders in the colonic mucosal lining and blood serum are more frequently observed in case of EC MSI + phenotype.
2. Similarity of pathogenesis in terms of EC and colon cancer is affected by similar phenotypic traits of patients as well as by MSI development.
References
Tyulyadіn, S. A., Nosov, D. A. & Perevodchіkova, N. І. (Eds) (2010) Mіnіmalnye klіnісheskіe rekomendacіі Yevropejskogo Obshhestva Onkologіі (ESMO) [ESMO Minimum Clinical Recommendations]. Moscow: Izdatelskaya gruppa RONC im. N.N. Blokhina RAMN. [in Russian].
Fedorenko, Z. P., Hulak, L. O., Mykhailovych, Y. U., et al. (2013) Biuleten Natsionalnoho kantser-reiestru Ukrainy [Bulletin of national cancer registry of Ukraine]. I. B. Shchepotin (Ed). Kyiv: Natsionalnyi instytut raku. [in Ukrainian].
Bilbao, C., Ramírez, R., Rodríguez, G., Falcón, O., León, L., Díaz-Chico, N., et al. (2010). Double strand break repair components are frequent targets of microsatellite instability in endometrial cancer. European Journal of Cancer, 46(15), 2821–2827.
Abbaszadegan, M. R., Asadzadeh Aghdayi, H., Rastin, F., Dadkhah, E., Lotfalizadeh, M., Mohamadian Roshan, N., Farzadnia, M., et al. (2009) Microsatellite Instability in Young Women with Endometrioid type Endometrial Cancer. Iranian Journal of Public Health, 38(3), 24–30.
Masuda, K., Banno, K., Hirasawa, A., Yanokura, M., Tsuji, K., Kobayashi, Y., Kisu, I., et al. (2012) Relationship of lower uterine segment cancer with Lynch syndrome: a novel case with an hMLH1 germline mutation. Oncology Reports, 28(5), 1537–1543.
Fedyanin, M. Yu., Tryakin, A. A. & Tyulyadіn, S. A. (2012) Rol' mikrosatellitnoj nestabil'nosti pri rake tolstoj kishki [The role of microsatellite instability in colon cancer]. Onkologicheskaya koloproktologiya, 3, 19–25.
Anker, P., Mulcahy, H., Chen, X.Q. & Stroun, M. (1999) Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer and Metastasis Reviews, 18, 65–73.
Zheng, Y. Y., Xie, L., Liu, L., Zhang, S. P., Wu, X. B., Zhu, C. L., Lai, R. S. (2012) BAT-25 polymorphism in Chinese from Jiangsu province and its implication for locus microsatellite instability screening. The International Journal of Biological Markers, 27(3), 227–231.
Carey. N. (2012) E`pigenetika: kak sovremennaya biologiya perepisyvaet nashi predstavleniya o genetike, zabolevaniyakh i nasledstvennosti [The Epigenetics Revolution: how modern Biology is Rewriting our Understanding of Genetics, Disease and Inheritance]. Rostov-na-Donu: Feniks. [in Russian].
Tinelli, A., Mezzolla, V., Leo, G., Pisano, M., Storelli, F., Alemanno, G., Malvasim, A. et al. (2010) Microsatellite instability (MSI) as genomic markers in endometrial cancer: toward scientific evidences. Mini-Reviews in Medicinal Chemistry, 10(14), 1356–1365.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
